New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export PFE’s income statement to Excel — free account
Pfizer Inc.
PFEHealthcare Drug Manufacturers General
Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024.
- Revenue
- −0.43%
- EPS
- −9.68%
- Free cash flow
- +20.0%
- Total debt
- +1.55%
Quarter to September 2026, against a year earlier
27.71
0.14
+0.51%
Follow PFE
Alert me
Pfizer Inc. (PFE) SEC filings, changes and red flags
Red flags
-
Officer departure
Pfizer Inc. reported the departure of an officer or director
Filings
| Form | Period | Filed | What it reports | Flags |
|---|---|---|---|---|
| 8-K | Oct 30, 2026 | 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits | Officer departure | |
| 10-Q | Sep 27, 2026 |
P1I2: 14 added · 11 removed · 67 modified P2I1A: no comparison — incorporated by reference |
||
| 8-K | Nov 3, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 28, 2026 |
P1I2: 37 added · 7 removed · 50 modified P2I1A: no comparison — incorporated by reference |
||
| 8-K | Aug 4, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Jun 18, 2026 | 7.01 Regulation FD disclosure | ||
| 8-K | Jun 18, 2026 | 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits | ||
| 10-Q | Mar 29, 2026 |
P1I2: 18 added · 63 removed · 69 modified P2I1A: no comparison — incorporated by reference |
||
| 8-K | May 5, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Apr 23, 2026 | 5.07 Submission of matters to a vote of security holders | ||
| 10-K | Dec 31, 2025 |
1: 35 added · 24 removed · 77 modified 1A: 8 added · 2 removed · 48 modified 7: 39 added · 50 removed · 71 modified |
||
| 8-K | Feb 3, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Dec 16, 2025 | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Nov 18, 2025 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Nov 13, 2025 | 8.01 Other events | ||
| 10-Q | Sep 28, 2025 |
P1I2: 24 added · 15 removed · 64 modified P2I1A: no comparison — incorporated by reference |
||
| 8-K | Nov 4, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 29, 2025 |
P1I2: 19 added · 12 removed · 67 modified P2I1A: no comparison — incorporated by reference |
||
| 8-K | Aug 5, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Mar 30, 2025 |
P1I2: no comparison — the earlier filing's text is no longer kept P2I1A: no comparison — incorporated by reference |
||
| 8-K | Apr 29, 2025 | 2.02 Results of operations and financial condition; 2.05 Costs of exit or disposal activities; 9.01 Financial statements and exhibits | ||
| 10-K | Dec 31, 2024 |
1: no comparison — no earlier filing on file 1A: no comparison — no earlier filing on file 7: no comparison — no earlier filing on file |
||
| 8-K | Feb 4, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 29, 2024 | |||
| 8-K | Oct 29, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2024 | |||
| 8-K | Jul 30, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | May 1, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Jan 30, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Dec 14, 2023 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits |